Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
NCT ID: NCT01018732
Description: All the AEs reported were solicited post-injection reactions
Frequency Threshold: 5
Time Frame: safety was assessed up to 28 days after vaccination.
Study: NCT01018732
Study Brief: A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
I: MenACWY-CRM Vaccine Subjects had been given one dose of Meningococcal ACWY (MenACWY)vaccine conjugated to CRM197 (cross-reactive material-mutant of diptheria toxin) 5 years ago None None 0 50 38 50 View
II: Licensed Polysaccharide Meningococcal Vaccine Subjects had been given one dose of licensed Meningococcal (Men ACWY) polysaccharide vaccine (Menomune) 5 years ago None None 0 50 36 50 View
III: Meningococcal Naive Subjects were between 16 years to 23 years (age-inclusive)and meningococcal vaccine naive None None 0 53 46 53 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site induration SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Malaise SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Chills SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Injection site erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View